LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Assets in USD from Q2 2011 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Lifecore Biomedical, Inc. \De\ quarterly Assets history and growth rate from Q2 2011 to Q1 2025.
  • Lifecore Biomedical, Inc. \De\ Assets for the quarter ending February 23, 2025 was $238M, a 3.47% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 $238M -$8.55M -3.47% Feb 23, 2025 10-Q 2025-04-03
Q4 2024 $255M +$9.57M +3.89% Nov 24, 2024 10-Q 2025-01-02
Q3 2024 $247M +$1.2M +0.49% Aug 25, 2024 10-Q 2024-10-04
Q2 2024 $254M +$415K +0.16% May 26, 2024 10-Q 2025-04-03
Q1 2024 $246M +$9.59M +4.05% Feb 25, 2024 10-Q 2024-08-09
Q4 2023 $246M -$30.2M -10.9% Nov 26, 2023 10-Q 2024-08-09
Q3 2023 $246M -$20.8M -7.79% Aug 27, 2023 10-Q 2024-08-09
Q2 2023 $254M -$21.2M -7.7% May 28, 2023 10-K 2024-08-26
Q1 2023 $237M -$87.6M -27% Feb 26, 2023 10-K 2024-03-20
Q4 2022 $276M -$145M -34.5% Nov 27, 2022 10-K 2024-03-20
Q3 2022 $266M -$178M -40.1% Aug 28, 2022 10-K 2024-03-20
Q2 2022 $275M -$227M -45.3% May 29, 2022 10-K 2024-03-20
Q1 2022 $324M -$183M -36% Feb 27, 2022 10-K 2024-03-20
Q4 2021 $421M -$76.8M -15.4% Nov 28, 2021 10-K 2024-03-20
Q3 2021 $445M -$58.3M -11.6% Aug 29, 2021 10-K 2024-03-20
Q2 2021 $502M +$208M +71% May 30, 2021 10-K 2024-03-20
Q1 2021 $507M -$43.2M -7.85% Feb 28, 2021 10-K 2024-03-20
Q4 2020 $498M -$61.9M -11.1% Nov 29, 2020 10-K 2024-03-20
Q3 2020 $503M -$43.1M -7.89% Aug 30, 2020 10-K 2024-03-20
Q2 2020 $294M -$226M -43.5% May 31, 2020 10-K/A 2023-03-16
Q1 2020 $550M +$48.5M +9.67% Feb 23, 2020 10-Q 2020-04-03
Q4 2019 $560M +$148M +36% Nov 24, 2019 10-Q 2020-01-02
Q3 2019 $546M +$143M +35.6% Aug 25, 2019 10-Q 2019-10-03
Q2 2019 $519M +$114M +28.3% May 26, 2019 10-K 2021-07-29
Q1 2019 $502M +$116M +30% Feb 24, 2019 10-Q 2019-04-04
Q4 2018 $412M +$32.3M +8.53% Nov 25, 2018 10-Q 2019-01-07
Q3 2018 $403M +$35.9M +9.79% Aug 26, 2018 10-Q 2018-10-05
Q2 2018 $405M +$46.1M +12.9% May 27, 2018 10-K 2020-08-14
Q1 2018 $386M +$39.7M +11.5% Feb 25, 2018 10-Q 2018-04-05
Q4 2017 $379M +$38M +11.1% Nov 26, 2017 10-Q 2018-01-05
Q3 2017 $367M +$23.2M +6.75% Aug 27, 2017 10-Q 2017-09-28
Q2 2017 $359M +$16M +4.66% May 28, 2017 10-K 2019-08-01
Q1 2017 $346M +$17.5M +5.31% Feb 26, 2017 10-Q 2017-04-07
Q4 2016 $341M -$19.8M -5.47% Nov 27, 2016 10-Q 2017-01-05
Q3 2016 $344M +$1.19M +0.35% Aug 28, 2016 10-Q 2016-09-29
Q2 2016 $343M -$3.81M -1.1% May 29, 2016 10-K 2018-08-09
Q1 2016 $329M -$11.6M -3.42% Feb 28, 2016 10-Q 2016-03-30
Q4 2015 $361M +$20M +5.87% Nov 29, 2015 10-Q 2016-01-07
Q3 2015 $343M +$16.6M +5.11% Aug 30, 2015 10-Q 2015-10-01
Q2 2015 $346M +$32.8M +10.5% May 31, 2015 10-K/A 2018-03-15
Q1 2015 $340M +$33.5M +10.9% Mar 1, 2015 10-Q 2015-04-02
Q4 2014 $341M +$38.8M +12.9% Nov 30, 2014 10-Q 2015-01-09
Q3 2014 $326M +$35.1M +12.1% Aug 31, 2014 10-Q 2014-10-08
Q2 2014 $314M +$22.7M +7.8% May 25, 2014 10-K 2016-08-01
Q1 2014 $307M +$23.8M +8.41% Feb 23, 2014 10-Q 2014-03-28
Q4 2013 $302M +$24.1M +8.68% Nov 24, 2013 10-Q 2014-01-03
Q3 2013 $291M +$20M +7.37% Aug 25, 2013 10-Q 2013-09-26
Q2 2013 $291M +$13.3M +4.77% May 26, 2013 10-K 2015-07-31
Q1 2013 $283M +$71.4M +33.8% Feb 24, 2013 10-Q 2013-04-04
Q4 2012 $278M +$68.7M +32.8% Nov 25, 2012 10-Q 2013-01-04
Q3 2012 $271M +$62M +29.7% Aug 26, 2012 10-Q/A 2013-01-02
Q2 2012 $278M +$71.4M +34.6% May 27, 2012 10-K 2014-08-01
Q1 2012 $212M Feb 26, 2012 10-Q 2012-03-28
Q4 2011 $209M Nov 27, 2011 10-Q 2012-01-05
Q3 2011 $209M Aug 28, 2011 10-Q 2011-10-05
Q2 2011 $206M May 29, 2011 10-K 2012-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.